Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. Cencora (NYSE:COR) announced a notable 15% price ...

Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal. RCA is a management services organization that operates a network of retina ...